|As of October 31, 2016|
|Issued and Outstanding||31,751,977|
Nass Valley has entered into a “Letter of Intent” as basis for a “Definitive Acquisition and Share Exchange” agreement (“DASE-Agr”) with Advanced Bioceutical Limited “APL”), a in New Jersey incorporated private Company, that upon the approval by the Canadian Securities Exchange (“CSE”), APL will become a wholly owned subsidiary of Nass Valley as “Resulting Issuer” of the transaction.
As the LOI is the basis for the shortly to be executed DASE-Agr. the Company’s shares may continue to be halted until that approval for the transaction has been received by the CSE.